08:38 : Keryx Biopharmaceuticals (KERX) jumps 7.4% after announcing an independent -
Keryx Biopharmaceuticals (KERX) jumps 7.4% after announcing an independent agency has recommended the company's Phase 3 study of its Perifosine drug for treating Colorectal Cancer continue to completion. AEterna Zentaris|Aeterna ...